U.S. oncology-focused biotechnology company Bio-Path Holdings Inc. has completed its previously announced $18.5 million share offering.

The company issued and sold 712,910 shares of its common stock for a price of $25.95 per share.

Bio-Path Holdings plans to use the net proceeds for working capital and general corporate purposes.

U.S. investment bank H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.